Chugai unveils results from study for NMOSD drug satralizumab
Chugai has announced results from the Phase III study for NMOSD drug satralizumab. Credit: Michal Jarmoluk from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more